#Ventilatory

Niall Ferguson

nialldferguson

1/9- Just coming off a week on call in the MSICU at TGH with @ecgoligher. Started the week with 6 COVID+ patients and we transferred in 12 more, mostly for

C. Michael Gibson MD

CMichaelGibson

ThreadAmazing at this point how little we know about #coronavirus:1. We have a range of R0 from 2.0 to 5.7; that is a massive range. 2. Do we know if

A. Adeni

AldrinAU

1/10 Just sharing an interesting #respiratory case. A 78yrs lady with #COPD, #cardiacfailure & elevated BMI was treated for cardiac failure, hypercapnoeic acidotic respiratory failure with #NIV(BiPAP) & diuretics. 2/10

A Kind Coconut

_ProudCoconut_

5G THREAD!! Don’t take my tweets as truth, get off your arse and do your own research please. All the information I’ve gathered is from a collective of qualified doctors,

Maximilian Konig

MaxKonigMD

A 2nd case series on IL-6 inhibition in COVID-ARDS.- n=21- no control group- ~1/3 got better- ~1/3 got worse- ~1/3 was the same (still in ARDS)- CRP improved (read: they

Nick Mark MD

nickmmark

Lots of talk about funny hemoglobin and ‘happy hypoxic’ people with #COVID19. I think we can explain everything using plain old pulmonary physiology. Let’s dive into hypoxic pulmonary vasoconstriction (HPV)

Jason Pogue

jpogue1

This is a great read on the nuance/trying to make sense of the remdesivir data! I highly respect @PaulSaxMD and his interpretation and clinical experience. This is how I want

Marcio S Bittencourt

MBittencourtMD

It is no news that the Dexa trial is out in preprint. Great work! Many have been calling it practice changing and have suggested Dexa should be used in all

Ed Ostrin, MD, PhD

phlegmMDPhD

There's an emerging theory that the profound hypoxia by COVID is due to a sort of hemoglobinopathy caused by direct viral protein binding to heme. I suppose anything is possible,

Vinay Prasad MD MPH

VPrasadMDMPH

Ok, here is a little #Tweetorial about #COVID19 and whether, outside of a controlled trial, we should be using different:1. rules for anti-coagulation/ lytics2. ventilatory settings in ARDS3. anti-virals/ anti-inflammatories

Thomas Piraino RRT

respresource

1/ I want to take some time to explain why I share anecdotal articles describing ‘differences’ in COIVD19 patients by @gattinon. The hospital I work at with has been taking

Peter A Smith

PeterAdamSmith

Scotland’s preparedness in numbers (thread):An NHS overwhelmed by COVID-19 could be, as seen in Italy, the difference between life & death. It could be the difference between everyone getting treatment

Francisco Marty, MD

FranciscoMarty_

Time to share some thoughts and questions following the .@medrxivpreprint first release of results from the #SolidarityTrial that compared local standard care to #remdesivir, #HydroxyChloroquine #lopinavir_ritonavir and #interferon for trea

Catherine Collins

RD_Catherine

How interesting to see my work discussed during this #COVIDー19 discussion on lower RQ feeding as treatment modality in respiratory failure. @DrPaulMason 1/7https://twitter.com/DrAseemMalhotra/status/1245225579286323203 Small study. We

Panteleimon ("Paddy") Ekkekakis

Ekkekakis

Inspired by the latest article by @GretchenReynold in @NYTHealth about how even initially reluctant adults discover how pleasant HIIT can be, I wanted to share some tips for colleagues who

Joanna Poole 💙

Jopo_dr

In my opinion it is exactly ARDS. It fits the criteria and would be included in trials. Indeed, having meta-analysed pressures and tidal volumes in several RCTS of ARDS in